SR
Surrozen, Inc. Warrant (SRZNW)
NASDAQ·Healthcare·Biotechnology
$0.02
+6.18%
Mkt Cap $138.86K
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$253.00
Range $171.60 – $297.00
Implied Upside
+1401484.4%
Consensus $253.00 vs current $0.02